Tenet Healthcare (NYSE:THC) Price Target Lowered to $242.00 at Guggenheim

Tenet Healthcare (NYSE:THC) had its price target cut by equities researchers at Guggenheim from $252.00 to $242.00 in a report released on Monday,Benzinga reports. The brokerage presently has a “buy” rating on the stock. Guggenheim’s target price would indicate a potential upside of 24.18% from the company’s previous close.

THC has been the topic of a number of other reports. Morgan Stanley set a $254.00 price objective on Tenet Healthcare in a research report on Friday, May 1st. Royal Bank Of Canada reduced their target price on Tenet Healthcare from $277.00 to $236.00 and set an “outperform” rating on the stock in a report on Friday, May 1st. TD Cowen decreased their price objective on shares of Tenet Healthcare from $242.00 to $233.00 and set a “buy” rating on the stock in a report on Monday, June 22nd. KeyCorp lowered their target price on Tenet Healthcare from $250.00 to $225.00 and set an “overweight” rating for the company in a research note on Friday, May 1st. Finally, Wells Fargo & Company upped their price target on Tenet Healthcare from $213.00 to $231.00 and gave the company an “overweight” rating in a research note on Monday, July 13th. Eighteen analysts have rated the stock with a Buy rating and four have given a Hold rating to the company. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $244.84.

Tenet Healthcare Stock Performance

THC opened at $194.89 on Monday. The company has a market cap of $16.79 billion, a PE ratio of 10.13, a price-to-earnings-growth ratio of 1.61 and a beta of 1.27. The company has a debt-to-equity ratio of 1.96, a quick ratio of 1.30 and a current ratio of 1.36. The stock has a 50-day moving average of $184.35 and a 200-day moving average of $197.45. Tenet Healthcare has a 52-week low of $146.60 and a 52-week high of $247.21.

Tenet Healthcare (NYSE:THC) last announced its earnings results on Thursday, April 30th. The company reported $4.82 EPS for the quarter, topping the consensus estimate of $4.21 by $0.61. The firm had revenue of $5.37 billion for the quarter, compared to the consensus estimate of $5.39 billion. Tenet Healthcare had a net margin of 7.94% and a return on equity of 25.55%. The business’s quarterly revenue was up 2.6% on a year-over-year basis. During the same quarter last year, the firm posted $4.36 EPS. Tenet Healthcare has set its FY 2026 guidance at 16.380-18.68 EPS. As a group, equities research analysts forecast that Tenet Healthcare will post 17.5 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other Tenet Healthcare news, Director Nadja West sold 3,000 shares of Tenet Healthcare stock in a transaction on Wednesday, May 27th. The shares were sold at an average price of $177.35, for a total transaction of $532,050.00. Following the completion of the sale, the director owned 24,805 shares of the company’s stock, valued at approximately $4,399,166.75. The trade was a 10.79% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director J Robert Kerrey sold 5,638 shares of the stock in a transaction on Thursday, May 28th. The shares were sold at an average price of $174.52, for a total value of $983,943.76. Following the completion of the transaction, the director directly owned 16,804 shares in the company, valued at approximately $2,932,634.08. This trade represents a 25.12% decrease in their position. The SEC filing for this sale provides additional information. 0.97% of the stock is currently owned by insiders.

Institutional Trading of Tenet Healthcare

Institutional investors and hedge funds have recently modified their holdings of the stock. Triumph Capital Management acquired a new stake in shares of Tenet Healthcare in the 3rd quarter valued at approximately $25,000. Activest Wealth Management bought a new stake in Tenet Healthcare in the fourth quarter valued at approximately $26,000. Elyxium Wealth LLC acquired a new stake in Tenet Healthcare in the fourth quarter worth $29,000. Canada Pension Plan Investment Board acquired a new position in shares of Tenet Healthcare in the 2nd quarter valued at $35,000. Finally, Meeder Asset Management Inc. increased its position in shares of Tenet Healthcare by 146.2% in the 4th quarter. Meeder Asset Management Inc. now owns 192 shares of the company’s stock valued at $38,000 after buying an additional 114 shares in the last quarter. 95.44% of the stock is owned by institutional investors.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.